BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ye Y, Shi ZL, Ren ZC, Sun YL. Furazolidone-induced pulmonary toxicity in Helicobacter pylori infection: Two case reports. World J Clin Cases 2023; 11(12): 2832-2838 [PMID: 37214582 DOI: 10.12998/wjcc.v11.i12.2832]
URL: https://www.wjgnet.com/2307-8960/full/v11/i12/2832.htm
Number Citing Articles
1
FurazolidoneReactions Weekly 2023; 1958(1): 241 doi: 10.1007/s40278-023-39915-6
2
Chao Wang, He-Jie Wang, Keng Li, Yin Wang, Yuan-Yuan Lin, Cheng-Zhao Weng, Jie Chen, Shao-Hua Xie, Wei Jiang, Yu-Cheng Zhu. Clinical Impact of High-dose Esomeprazole-amoxicillin Dual Therapy as Rescue Treatment for Helicobacter pylori InfectionJournal of Clinical Gastroenterology 2024;  doi: 10.1097/MCG.0000000000002100
3
Shan Xu, Xiaohong Wu, Enguo Chen, Kejing Ying. Anti‐Helicobacter pylori Infection Treatment and Pulmonary Hypersensitivity: Case Series and Review of the LiteratureThe Clinical Respiratory Journal 2024; 18(8) doi: 10.1111/crj.13816
4
Cong Zheng, Yao Cheng, Ping Huang, Miaomiao Zhang, Zhuochao Ren, Xiaochun Zheng, Zixue Xuan, Bin Shen, Xiuli Yang. Pulmonary adverse reaction caused by furazolidone: Two case reports and a literature reviewMedicine 2024; 103(33): e39286 doi: 10.1097/MD.0000000000039286